Abstract
There is no vaccine against dental caries on the market and the lack of appropriate antigens and delivery mucosal vectors are among the main reason for such situation. B. subtilis is used as expression system of heterologous proteins and as vaccine vehicle administered by mucosal routes. This project aims the development of genetically modified B. subtilis strains as a platform for the de…